Resmed (RSMDF) Treasury Shares (2010 - 2026)

Resmed (RSMDF) has reported Treasury Shares for 17 consecutive years, with $2.8 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Treasury Shares rose 35.05% year-over-year to $2.8 billion; the trailing twelve-month figure through Jun 2026 stood at $2.8 billion (up 35.05% YoY), and the FY2026 full-year result was $2.8 billion, up 35.05% from the prior year.
• Treasury Shares grew to $2.8 billion in Q2 2026 per RSMDF's latest filing, from $2.6 billion in the prior quarter.
• Across five years, Treasury Shares topped out at $46.8 million in Q2 2026 and bottomed at $41.8 million in Q1 2022.
• Historically, Treasury Shares has averaged $43.1 million across 5 years, with a median of $42.5 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Treasury Shares changed 0.0% in 2022, then jumped 35.05% in 2026.
• Over 5 years, Treasury Shares stood at $1.6 billion in 2022, then grew by 3.08% to $1.7 billion in 2023, then rose by 13.45% to $1.9 billion in 2024, then rose by 26.45% to $2.4 billion in 2025, then increased by 16.65% to $2.8 billion in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $2.8 billion, $2.6 billion, and $2.4 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.